Skip to content

Mazdutide: Dosage & Administration

Part of the Mazdutide Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Dosage Protocols

PhaseDoseRouteFrequency
Phase 2 (T2D)3–6 mgSC injectionWeekly
Phase 3 (Obesity)4.5–6 mgSC injectionWeekly

Dose escalation over 8–12 weeks to minimize GI side effects. Not commercially available — all dosing from published trial protocols.

Administration

Clinical trial formulations are pre-filled injection pens. Mazdutide is not available as a research peptide for reconstitution. Subcutaneous injection in abdomen, thigh, or upper arm.

Timing

Weekly injection on the same day each week. Long-term continuous use anticipated (similar to GLP-1 agonist paradigm). Phase 3 trials evaluate 48-week treatment periods.

Storage

  • Clinical formulations: 2–8°C
  • Do not freeze
  • Protect from light

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.